Atorvastatin Calcium Tablet
Product Images NDC 68180-635
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68180-635). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1: Effect Of Atorvastatin Calcium 10 mg/day On Cumulative Incidence Of Non-fatalmyocardial Infarction Or Coronary Heart Disease Death (in Ascot-lla) (D800d38e 825d 41d4 B833 0e693d0851e0 02)
Figure 2: Effect Of Atorvastatin Calcium 10 mg/day On Time To Occurrence Of Major Cardiovascular Event (myocardial Infarction, Acute Chd Death, Unstable Angina, Coronary Revascularization, Or Stroke) (D800d38e 825d 41d4 B833 0e693d0851e0 03)
Figure 3: Effect Of Atorvastatin Calcium 80 mg/day Vs. 10 mg/day On Time To Occurrence Of Major Cardiovascular Events (tnt) (D800d38e 825d 41d4 B833 0e693d0851e0 04)
05 (D800d38e 825d 41d4 B833 0e693d0851e0 05)
06 (D800d38e 825d 41d4 B833 0e693d0851e0 06)
06 (D800d38e 825d 41d4 B833 0e693d0851e0 07)
07 (D800d38e 825d 41d4 B833 0e693d0851e0 08)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.